Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) EBIT Margin (2016 - 2025)

Milestone Scientific's EBIT Margin history spans 16 years, with the latest figure at 48.07% for Q3 2025.

  • For Q3 2025, EBIT Margin rose 1219.0% year-over-year to 48.07%; the TTM value through Sep 2025 reached 75.25%, up 67.0%, while the annual FY2024 figure was 78.8%, 648.0% down from the prior year.
  • EBIT Margin for Q3 2025 was 48.07% at Milestone Scientific, up from 64.56% in the prior quarter.
  • Across five years, EBIT Margin topped out at 33.66% in Q1 2021 and bottomed at 175.01% in Q2 2022.
  • The 5-year median for EBIT Margin is 78.27% (2023), against an average of 81.24%.
  • The largest annual shift saw EBIT Margin skyrocketed 177388bps in 2021 before it crashed -5659bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 54.13% in 2021, then crashed by -64bps to 88.67% in 2022, then grew by 1bps to 87.57% in 2023, then fell by -18bps to 103.57% in 2024, then soared by 54bps to 48.07% in 2025.
  • Per Business Quant, the three most recent readings for MLSS's EBIT Margin are 48.07% (Q3 2025), 64.56% (Q2 2025), and 89.59% (Q1 2025).